(S (S (VP (VBG Understanding) (NP (NP (DT the) (JJ temporal) (NNS dynamics)) (PP (IN of) (NP (NN COVID) (HYPH -) (CD 19)))))) (NP (NN patient) (NNS phenotypes)) (VP (VBZ is) (ADJP (JJ necessary) (S (VP (TO to) (VP (VB derive) (NP (NP (ADJP (JJ fine) (HYPH -) (JJ grained)) (NN resolution)) (PP (IN of) (NP (NN pathophysiology))))))))) (. .))
(S (ADVP (RB Here)) (NP (PRP we)) (VP (VBP use) (NP (NML (NML (NN state)) (HYPH -) (PP (IN of) (HYPH -) (NP (DT the) (HYPH -) (NN art)))) (ADJP (NP (NP (JJ deep) (JJ neural) (NNS networks)) (PP (IN over) (NP (DT an) (NN institution)))) (HYPH -) (JJ wide)) (NN machine) (NN intelligence) (NN platform)) (PP (IN for) (NP (NP (DT the) (VBN augmented) (NN curation)) (PP (IN of) (NP (NP (QP (CD 15.8) (CD million)) (JJ clinical) (NNS notes)) (PP (IN from) (NP (NP (CD 30,494) (NNS patients)) (VP (VBN subjected) (PP (IN to) (NP (NML (NML (NNP COVID) (HYPH -) (CD 19)) (NN PCR)) (JJ diagnostic) (NN testing))))))))))) (. .))
(S (PP (IN By) (S (VP (VBG contrasting) (NP (NP (DT the) (ADJP (NP (NP (NNP Electronic) (NNP Health) (NNP Record)) (-LRB- -LRB-) (NP (NNP EHR))) (-RRB- -RRB-) (HYPH -) (VBN derived)) (JJ clinical) (NNS phenotypes)) (PP (IN of) (NP (NP (NNP COVID) (ADJP (ADJP (JJ -19-positive) (PRN (-LRB- -LRB-) (NP (NNP COVIDpos)) (, ,) (S (NP (NN n)) (VP (SYM =) (NP (CD 635)))) (-RRB- -RRB-))) (CC versus) (ADJP (NP (NNP COVID)) (JJ -19-negative) (PRN (-LRB- -LRB-) (NP (NNP COVIDneg)) (, ,) (S (NP (NN n)) (VP (SYM =) (NP (CD 29,859)))) (-RRB- -RRB-)))) (NNS patients)) (PP (IN over) (NP (NP (DT each) (NN day)) (PP (IN of) (NP (NP (DT the) (NN week)) (VP (VBG preceding) (NP (DT the) (NML (NN PCR) (NN testing)) (NN date))))))))))))) (, ,) (NP (PRP we)) (VP (VBP identify) (NP (NP (NN anosmia) (HYPH /) (NN dysgeusia) (PRN (-LRB- -LRB-) (ADVP (RB 37.4-fold)) (-RRB- -RRB-))) (, ,) (NP (NN myalgia) (HYPH /) (NN arthralgia) (PRN (-LRB- -LRB-) (NP (RB 2.6-fold)) (-RRB- -RRB-))) (, ,) (NP (NN diarrhea) (PRN (-LRB- -LRB-) (ADVP (RB 2.2-fold)) (-RRB- -RRB-))) (, ,) (NP (NP (NN fever) (HYPH /) (NNS chills)) (PRN (-LRB- -LRB-) (ADVP (RB 2.1-fold)) (-RRB- -RRB-))) (, ,) (NP (JJ respiratory) (NN difficulty) (PRN (-LRB- -LRB-) (ADVP (RB 1.9-fold)) (-RRB- -RRB-))) (, ,) (CC and) (NP (NN cough) (PRN (-LRB- -LRB-) (ADVP (RB 1.8-fold)) (-RRB- -RRB-)))) (SBAR (IN as) (S (ADVP (RB significantly)) (VP (VBN amplified) (PP (IN in) (NP (NP (NNP COVIDpos)) (PP (IN over) (NP (NNP COVIDneg) (NNS patients))))))))) (. .))
(S (NP (NP (DT The) (JJ specific) (NN combination)) (PP (IN of) (NP (NN cough) (CC and) (NN diarrhea)))) (VP (VP (VBZ has) (NP (NP (DT a) (JJ 3.2-fold) (NN amplification)) (PP (IN in) (NP (NP (NNP COVIDpos) (NNS patients)) (PP (IN during) (NP (NP (DT the) (NN week)) (PP (JJ prior) (IN to) (NP (NN PCR) (NN testing))))))))) (, ,) (CC and) (VP (ADVP (IN along) (PP (IN with) (NP (NN anosmia) (HYPH /) (NN dysgeusia)))) (, ,) (VBZ constitutes) (NP (NP (DT the) (ADJP (NP (NP (JJS earliest)) (NP (NN EHR))) (HYPH -) (VBN derived)) (NN signature)) (PP (IN of) (NP (NNP COVID) (HYPH -) (CD 19))) (PRN (-LRB- -LRB-) (NP (ADVP (NP (QP (CD 4) (SYM -) (CD 7)) (NNS days)) (RB prior) (PP (IN to) (NP (JJ typical) (NN PCR)))) (NN testing) (NN date)) (-RRB- -RRB-))))) (. .))
(S (NP (DT This) (NN study)) (VP (VBZ introduces) (NP (NP (DT an) (NML (NNP Augmented) (NNP Intelligence)) (NN platform)) (PP (IN for) (NP (NP (DT the) (NML (JJ real) (HYPH -) (NN time)) (NN synthesis)) (PP (IN of) (NP (NP (JJ institutional) (NN knowledge)) (VP (VBN captured) (PP (IN in) (NP (NNS EHRs)))))))))) (. .))
(S (NP (DT The) (NN platform)) (VP (VBZ holds) (NP (JJ tremendous) (NN potential)) (PP (IN for) (S (VP (VP (VBG scaling) (PRT (RP up)) (NP (NP (NN curation) (NN throughput)) (, ,) (PP (IN with) (NP (NP (JJ minimal) (NN need)) (PP (IN for) (NP (NP (VBG retraining)) (VP (VBG underlying) (NP (JJ neural) (NNS networks))))))))) (, ,) (ADVP (RB thus)) (VP (VBG promising) (NP (ADJP (NP (NNP EHR)) (HYPH -) (VBN powered)) (JJ early) (NN diagnosis)) (PP (IN for) (NP (NP (DT a) (JJ broad) (NN spectrum)) (PP (IN of) (NP (NNS diseases)))))))))) (. .))
